Literature DB >> 15262739

Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.

Joonmi Oh1, Daniel Pelletier, Sarah J Nelson.   

Abstract

BACKGROUND: Axonal damage has been observed in normal-appearing white matter (NAWM) for patients with multiple sclerosis (MS).
OBJECTIVES: To investigate changes in brain metabolite ratios in a region of normal-appearing corpus callosum (CC) for patients with MS and to test its relationship to changes in other regions of NAWM. DESIGN AND METHODS: Data were collected from 24 patients with MS and 15 control subjects. Two-dimensional proton magnetic resonance spectroscopic imaging was performed centered at the CC. Regions of interest from normal-appearing CC were manually segmented using anatomical images. The NAWM outside the CC region was segmented based on the signal intensity in T1- and T2-weighted images.
RESULTS: The N-acetylaspartate-creatine-phosphocreatine ratio was lower in both regions for patients with secondary progressive MS compared with the controls; the N-acetylaspartate-creatine-phosphocreatine was lower only in the normal-appearing CC region for patients with relapsing-remitting MS (P<.001) compared with the controls. The ratio of choline-containing compound compared with the creatine-phosphocreatine ratio was also lower in the region of normal-appearing CC for patients with relapsing-remitting MS (P =.003) compared with the controls. There was a correlation between the N-acetylaspartate-creatine-phosphocreatine ratio in the normal-appearing CC and T1 lesions (r = -0.53, P =.01) for all patients.
CONCLUSIONS: The CC was a more sensitive location for depicting axonal injury than other regions of NAWM. A correlation between the reduction of the N-acetylaspartate-creatine-phosphocreatine ratio in the normal-appearing CC and the T1 lesions may suggest that transection of axons in lesions may cause distant axonal damage and/or dysfunction that are expressed and more sensitively detectable in the CC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262739     DOI: 10.1001/archneur.61.7.1081

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.

Authors:  Stephanie C Manson; Jacqueline Palace; Joseph A Frank; Paul M Matthews
Journal:  Exp Brain Res       Date:  2006-06-21       Impact factor: 1.972

2.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

Review 3.  Brain atrophy and cognitive impairment in multiple sclerosis: a review.

Authors:  Michael Lanz; Horst K Hahn; Helmut Hildebrandt
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

4.  Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy.

Authors:  Emily T Wood; Itamar Ronen; Aranee Techawiboonwong; Craig K Jones; Peter B Barker; Peter Calabresi; Daniel Harrison; Daniel S Reich
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

Review 5.  Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

Authors:  Jae Young Lee; Kasra Taghian; Steven Petratos
Journal:  Acta Neuropathol Commun       Date:  2014-08-27       Impact factor: 7.801

6.  Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.

Authors:  Emily Turner Wood; Ece Ercan; Pascal Sati; Irene C M Cortese; Itamar Ronen; Daniel S Reich
Journal:  Neuroimage Clin       Date:  2017-06-22       Impact factor: 4.881

Review 7.  Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker.

Authors:  Kelley M Swanberg; Karl Landheer; David Pitt; Christoph Juchem
Journal:  Front Neurol       Date:  2019-11-15       Impact factor: 4.003

8.  Diffusion basis spectrum imaging provides insights into MS pathology.

Authors:  Peng Sun; Ajit George; Dana C Perantie; Kathryn Trinkaus; Zezhong Ye; Robert T Naismith; Sheng-Kwei Song; Anne H Cross
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.